A citation-based method for searching scientific literature

Aparna R Parikh, Ignaty Leshchiner, Liudmila Elagina, Lipika Goyal, Chaya Levovitz, Giulia Siravegna, Dimitri Livitz, Kahn Rhrissorrakrai, Elizabeth E Martin, Emily E Van Seventer, Megan Hanna, Kara Slowik, Filippo Utro, Christopher J Pinto, Alicia Wong, Brian P Danysh, Ferran Fece de la Cruz, Isobel J Fetter, Brandon Nadres, Heather A Shahzade, Jill N Allen, Lawrence S Blaszkowsky, Jeffrey W Clark, Bruce Giantonio, Janet E Murphy, Ryan D Nipp, Eric Roeland, David P Ryan, Colin D Weekes, Eunice L Kwak, Jason E Faris, Jennifer Y Wo, François Aguet, Ipsita Dey-Guha, Mehlika Hazar-Rethinam, Dora Dias-Santagata, David T Ting, Andrew X Zhu, Theodore S Hong, Todd R Golub, A John Iafrate, Viktor A Adalsteinsson, Alberto Bardelli, Laxmi Parida, Dejan Juric, Gad Getz, Ryan B Corcoran. Nat Med 2019
Times Cited: 131







List of co-cited articles
1031 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Detection of circulating tumor DNA in early- and late-stage human malignancies.
Chetan Bettegowda, Mark Sausen, Rebecca J Leary, Isaac Kinde, Yuxuan Wang, Nishant Agrawal, Bjarne R Bartlett, Hao Wang, Brandon Luber, Rhoda M Alani,[...]. Sci Transl Med 2014
36

Liquid biopsies come of age: towards implementation of circulating tumour DNA.
Jonathan C M Wan, Charles Massie, Javier Garcia-Corbacho, Florent Mouliere, James D Brenton, Carlos Caldas, Simon Pacey, Richard Baird, Nitzan Rosenfeld. Nat Rev Cancer 2017
965
20

Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution.
Christopher Abbosh, Nicolai J Birkbak, Gareth A Wilson, Mariam Jamal-Hanjani, Tudor Constantin, Raheleh Salari, John Le Quesne, David A Moore, Selvaraju Veeriah, Rachel Rosenthal,[...]. Nature 2017
675
19

Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.
Marco Gerlinger, Andrew J Rowan, Stuart Horswell, M Math, James Larkin, David Endesfelder, Eva Gronroos, Pierre Martinez, Nicholas Matthews, Aengus Stewart,[...]. N Engl J Med 2012
19

Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients.
Giulia Siravegna, Benedetta Mussolin, Michela Buscarino, Giorgio Corti, Andrea Cassingena, Giovanni Crisafulli, Agostino Ponzetti, Chiara Cremolini, Alessio Amatu, Calogero Lauricella,[...]. Nat Med 2015
489
18

High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants.
Pedram Razavi, Bob T Li, David N Brown, Byoungsok Jung, Earl Hubbell, Ronglai Shen, Wassim Abida, Krishna Juluru, Ino De Bruijn, Chenlu Hou,[...]. Nat Med 2019
200
18

Detection and localization of surgically resectable cancers with a multi-analyte blood test.
Joshua D Cohen, Lu Li, Yuxuan Wang, Christopher Thoburn, Bahman Afsari, Ludmila Danilova, Christopher Douville, Ammar A Javed, Fay Wong, Austin Mattox,[...]. Science 2018
967
17

An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage.
Aaron M Newman, Scott V Bratman, Jacqueline To, Jacob F Wynne, Neville C W Eclov, Leslie A Modlin, Chih Long Liu, Joel W Neal, Heather A Wakelee, Robert E Merritt,[...]. Nat Med 2014
16

Integrating liquid biopsies into the management of cancer.
Giulia Siravegna, Silvia Marsoni, Salvatore Siena, Alberto Bardelli. Nat Rev Clin Oncol 2017
795
16

Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer.
Jeanne Tie, Yuxuan Wang, Cristian Tomasetti, Lu Li, Simeon Springer, Isaac Kinde, Natalie Silliman, Mark Tacey, Hui-Li Wong, Michael Christie,[...]. Sci Transl Med 2016
595
15

Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors.
Viktor A Adalsteinsson, Gavin Ha, Samuel S Freeman, Atish D Choudhury, Daniel G Stover, Heather A Parsons, Gregory Gydush, Sarah C Reed, Denisse Rotem, Justin Rhoades,[...]. Nat Commun 2017
256
13

Integrated digital error suppression for improved detection of circulating tumor DNA.
Aaron M Newman, Alexander F Lovejoy, Daniel M Klass, David M Kurtz, Jacob J Chabon, Florian Scherer, Henning Stehr, Chih Long Liu, Scott V Bratman, Carmen Say,[...]. Nat Biotechnol 2016
495
13

Analysis of circulating tumor DNA to monitor metastatic breast cancer.
Sarah-Jane Dawson, Dana W Y Tsui, Muhammed Murtaza, Heather Biggs, Oscar M Rueda, Suet-Feung Chin, Mark J Dunning, Davina Gale, Tim Forshew, Betania Mahler-Araujo,[...]. N Engl J Med 2013
13

Circulating mutant DNA to assess tumor dynamics.
Frank Diehl, Kerstin Schmidt, Michael A Choti, Katharine Romans, Steven Goodman, Meng Li, Katherine Thornton, Nishant Agrawal, Lori Sokoll, Steve A Szabo,[...]. Nat Med 2008
12

Enhanced detection of circulating tumor DNA by fragment size analysis.
Florent Mouliere, Dineika Chandrananda, Anna M Piskorz, Elizabeth K Moore, James Morris, Lise Barlebo Ahlborn, Richard Mair, Teodora Goranova, Francesco Marass, Katrin Heider,[...]. Sci Transl Med 2018
273
12

Current and future perspectives of liquid biopsies in genomics-driven oncology.
Ellen Heitzer, Imran S Haque, Charles E S Roberts, Michael R Speicher. Nat Rev Genet 2019
378
12

Direct detection of early-stage cancers using circulating tumor DNA.
Jillian Phallen, Mark Sausen, Vilmos Adleff, Alessandro Leal, Carolyn Hruban, James White, Valsamo Anagnostou, Jacob Fiksel, Stephen Cristiano, Eniko Papp,[...]. Sci Transl Med 2017
459
11

Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer.
Mariangela Russo, Giulia Siravegna, Lawrence S Blaszkowsky, Giorgio Corti, Giovanni Crisafulli, Leanne G Ahronian, Benedetta Mussolin, Eunice L Kwak, Michela Buscarino, Luca Lazzari,[...]. Cancer Discov 2016
232
11

Genome-wide cell-free DNA fragmentation in patients with cancer.
Stephen Cristiano, Alessandro Leal, Jillian Phallen, Jacob Fiksel, Vilmos Adleff, Daniel C Bruhm, Sarah Østrup Jensen, Jamie E Medina, Carolyn Hruban, James R White,[...]. Nature 2019
240
11

Liquid biopsies: genotyping circulating tumor DNA.
Luis A Diaz, Alberto Bardelli. J Clin Oncol 2014
11

Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA.
Muhammed Murtaza, Sarah-Jane Dawson, Dana W Y Tsui, Davina Gale, Tim Forshew, Anna M Piskorz, Christine Parkinson, Suet-Feung Chin, Zoya Kingsbury, Alvin S C Wong,[...]. Nature 2013
10

Sensitive tumour detection and classification using plasma cell-free DNA methylomes.
Shu Yi Shen, Rajat Singhania, Gordon Fehringer, Ankur Chakravarthy, Michael H A Roehrl, Dianne Chadwick, Philip C Zuzarte, Ayelet Borgida, Ting Ting Wang, Tiantian Li,[...]. Nature 2018
263
10

Utility of ctDNA to support patient selection for early phase clinical trials: the TARGET study.
Dominic G Rothwell, Mahmood Ayub, Natalie Cook, Fiona Thistlethwaite, Louise Carter, Emma Dean, Nigel Smith, Shaun Villa, Joanne Dransfield, Alexandra Clipson,[...]. Nat Med 2019
106
10

Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients.
Jacob J Chabon, Andrew D Simmons, Alexander F Lovejoy, Mohammad S Esfahani, Aaron M Newman, Henry J Haringsma, David M Kurtz, Henning Stehr, Florian Scherer, Chris A Karlovich,[...]. Nat Commun 2016
381
10

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
10

Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non-small Cell Lung Cancer.
Natasha B Leighl, Ray D Page, Victoria M Raymond, Davey B Daniel, Stephen G Divers, Karen L Reckamp, Miguel A Villalona-Calero, Daniel Dix, Justin I Odegaard, Richard B Lanman,[...]. Clin Cancer Res 2019
175
10

Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies.
Yoshiaki Nakamura, Hiroya Taniguchi, Masafumi Ikeda, Hideaki Bando, Ken Kato, Chigusa Morizane, Taito Esaki, Yoshito Komatsu, Yasuyuki Kawamoto, Naoki Takahashi,[...]. Nat Med 2020
54
18

Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non-Small Cell Lung Cancer.
Charu Aggarwal, Jeffrey C Thompson, Taylor A Black, Sharyn I Katz, Ryan Fan, Stephanie S Yee, Austin L Chien, Tracey L Evans, Joshua M Bauml, Evan W Alley,[...]. JAMA Oncol 2019
152
9

Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab.
David R Gandara, Sarah M Paul, Marcin Kowanetz, Erica Schleifman, Wei Zou, Yan Li, Achim Rittmeyer, Louis Fehrenbacher, Geoff Otto, Christine Malboeuf,[...]. Nat Med 2018
507
9

Liquid biopsy and minimal residual disease - latest advances and implications for cure.
Klaus Pantel, Catherine Alix-Panabières. Nat Rev Clin Oncol 2019
300
9

Tumour heterogeneity and resistance to cancer therapies.
Ibiayi Dagogo-Jack, Alice T Shaw. Nat Rev Clin Oncol 2018
836
9

Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer.
Tony S Mok, Yi-Long Wu, Myung-Ju Ahn, Marina C Garassino, Hye R Kim, Suresh S Ramalingam, Frances A Shepherd, Yong He, Hiroaki Akamatsu, Willemijn S M E Theelen,[...]. N Engl J Med 2017
9

Genomic Landscape of Cell-Free DNA in Patients with Colorectal Cancer.
John H Strickler, Jonathan M Loree, Leanne G Ahronian, Aparna R Parikh, Donna Niedzwiecki, Allan Andresson Lima Pereira, Matthew McKinney, W Michael Korn, Chloe E Atreya, Kimberly C Banks,[...]. Cancer Discov 2018
125
8

Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer.
Thomas Reinert, Tenna Vesterman Henriksen, Emil Christensen, Shruti Sharma, Raheleh Salari, Himanshu Sethi, Michael Knudsen, Iver Nordentoft, Hsin-Ta Wu, Antony S Tin,[...]. JAMA Oncol 2019
177
8

Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer.
Fabrice André, Eva Ciruelos, Gabor Rubovszky, Mario Campone, Sibylle Loibl, Hope S Rugo, Hiroji Iwata, Pierfranco Conte, Ingrid A Mayer, Bella Kaufman,[...]. N Engl J Med 2019
670
8

Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review.
Jason D Merker, Geoffrey R Oxnard, Carolyn Compton, Maximilian Diehn, Patricia Hurley, Alexander J Lazar, Neal Lindeman, Christina M Lockwood, Alex J Rai, Richard L Schilsky,[...]. J Clin Oncol 2018
377
8

How liquid biopsies can change clinical practice in oncology.
G Siravegna, B Mussolin, T Venesio, S Marsoni, J Seoane, C Dive, N Papadopoulos, S Kopetz, R B Corcoran, L L Siu,[...]. Ann Oncol 2019
88
9


Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer.
Jeanne Tie, Joshua D Cohen, Yuxuan Wang, Michael Christie, Koen Simons, Margaret Lee, Rachel Wong, Suzanne Kosmider, Sumitra Ananda, Joseph McKendrick,[...]. JAMA Oncol 2019
121
7

Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer.
Isaac Garcia-Murillas, Gaia Schiavon, Britta Weigelt, Charlotte Ng, Sarah Hrebien, Rosalind J Cutts, Maggie Cheang, Peter Osin, Ashutosh Nerurkar, Iwanka Kozarewa,[...]. Sci Transl Med 2015
624
7

Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling.
Aadel A Chaudhuri, Jacob J Chabon, Alexander F Lovejoy, Aaron M Newman, Henning Stehr, Tej D Azad, Michael S Khodadoust, Mohammad Shahrokh Esfahani, Chih Long Liu, Li Zhou,[...]. Cancer Discov 2017
317
7

Plasma ctDNA RAS mutation analysis for the diagnosis and treatment monitoring of metastatic colorectal cancer patients.
J Vidal, L Muinelo, A Dalmases, F Jones, D Edelstein, M Iglesias, M Orrillo, A Abalo, C Rodríguez, E Brozos,[...]. Ann Oncol 2017
159
7

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.
Dung T Le, Jennifer N Durham, Kellie N Smith, Hao Wang, Bjarne R Bartlett, Laveet K Aulakh, Steve Lu, Holly Kemberling, Cara Wilt, Brandon S Luber,[...]. Science 2017
7

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.
Ahmet Zehir, Ryma Benayed, Ronak H Shah, Aijazuddin Syed, Sumit Middha, Hyunjae R Kim, Preethi Srinivasan, Jianjiong Gao, Debyani Chakravarty, Sean M Devlin,[...]. Nat Med 2017
7

TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion-Positive Intrahepatic Cholangiocarcinoma.
Lipika Goyal, Lei Shi, Leah Y Liu, Ferran Fece de la Cruz, Jochen K Lennerz, Srivatsan Raghavan, Ignaty Leschiner, Liudmila Elagina, Giulia Siravegna, Raymond W S Ng,[...]. Cancer Discov 2019
113
7

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.
Dung T Le, Jennifer N Uram, Hao Wang, Bjarne R Bartlett, Holly Kemberling, Aleksandra D Eyring, Andrew D Skora, Brandon S Luber, Nilofer S Azad, Dan Laheru,[...]. N Engl J Med 2015
7


Liquid biopsy: monitoring cancer-genetics in the blood.
Emily Crowley, Federica Di Nicolantonio, Fotios Loupakis, Alberto Bardelli. Nat Rev Clin Oncol 2013
941
7

False-Positive Plasma Genotyping Due to Clonal Hematopoiesis.
Yuebi Hu, Bryan C Ulrich, Julianna Supplee, Yanan Kuang, Patrick H Lizotte, Nora B Feeney, Nicolas M Guibert, Mark M Awad, Kwok-Kin Wong, Pasi A Jänne,[...]. Clin Cancer Res 2018
180
7

Tracking the Evolution of Non-Small-Cell Lung Cancer.
Mariam Jamal-Hanjani, Gareth A Wilson, Nicholas McGranahan, Nicolai J Birkbak, Thomas B K Watkins, Selvaraju Veeriah, Seema Shafi, Diana H Johnson, Richard Mitter, Rachel Rosenthal,[...]. N Engl J Med 2017
999
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.